Andera Partners 13F holdings
Andera Partners reported 8 positions with a total reported value of $206.5M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-07-22. Top holdings by reported value: KMTS KESTRA MED TECHNOLOGIES LTD (33.6%), MLYS MINERALYS THERAPEUTICS INC (20.8%), AVLN AVALYN PHARMACEUTICALS INC (14.8%), AGMB AGOMAB THERAPEUTICS NV (9.7%), EVMN EVOMMUNE INC (9.0%). Against 2026-03-31 it opened 1 new position and exited 0. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Andera Partners files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
8 largest of 8 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| KMTS KESTRA MED TECHNOLOGIES LTD | 2,728,679 | $69.4M | 33.6% |
| MLYS MINERALYS THERAPEUTICS INC | 1,591,917 | $42.9M | 20.8% |
| AVLN AVALYN PHARMACEUTICALS INC | 929,824 | $30.6M | 14.8% |
| AGMB AGOMAB THERAPEUTICS NV | 1,538,702 | $20.0M | 9.7% |
| EVMN EVOMMUNE INC | 1,391,990 | $18.5M | 9.0% |
| IVA INVENTIVA SA | 3,633,181 | $13.7M | 6.7% |
| ABVX ABIVAX SA | 78,125 | $10.4M | 5.0% |
| NYXH NYXOAH S A | 522,057 | $882.3K | 0.4% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 1 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| AVLN AVALYN PHARMACEUTICALS INC | 929,824 | $30.6M | 14.8% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 0 in all · reported value as of 2026-03-31
No positions were sold out.
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| IVA INVENTIVA SA | 1,818,181 | 3,633,181 | +99.8% | $13.7M |
| KMTS KESTRA MED TECHNOLOGIES LTD | 2,695,192 | 2,728,679 | +1.2% | $69.4M |
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| EVMN EVOMMUNE INC | 1,897,362 | 1,391,990 | -26.6% | $18.5M |
CIK 1757283 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
